Tinavi Medical Technologies Co.,Ltd. (SHA:688277)
23.81
-0.38 (-1.57%)
At close: Mar 6, 2026
SHA:688277 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 260.2 | 310.86 | 211.39 | 287.11 |
Trading Asset Securities | - | - | 50.04 | 40.2 | 120.63 |
Cash & Short-Term Investments | 347.77 | 260.2 | 360.9 | 251.59 | 407.74 |
Cash Growth | 33.66% | -27.90% | 43.45% | -38.30% | -43.42% |
Accounts Receivable | - | 70.96 | 49.66 | 35.37 | 37.52 |
Other Receivables | - | 12.53 | 9.52 | 11.85 | 10.16 |
Receivables | - | 83.49 | 59.18 | 47.23 | 47.68 |
Inventory | - | 31.67 | 26.23 | 43.8 | 37.94 |
Prepaid Expenses | - | - | - | 2.99 | 2.75 |
Other Current Assets | - | 62.61 | 42.49 | 27.8 | 11.3 |
Total Current Assets | - | 437.97 | 488.8 | 373.41 | 507.42 |
Property, Plant & Equipment | - | 422.67 | 450.35 | 279.47 | 112.35 |
Long-Term Investments | - | 596.02 | 454.34 | 467.02 | 265.22 |
Other Intangible Assets | - | 16.34 | 10.28 | 6.69 | 7.61 |
Long-Term Accounts Receivable | - | 8.25 | 1.65 | - | 3.41 |
Long-Term Deferred Tax Assets | - | 54.19 | 77.87 | 86 | 54.16 |
Long-Term Deferred Charges | - | 32.54 | 13.85 | 19.38 | 20.23 |
Other Long-Term Assets | - | 123.73 | 122.34 | 174.98 | 308.64 |
Total Assets | - | 1,692 | 1,619 | 1,407 | 1,279 |
Accounts Payable | - | 27.84 | 27.79 | 22.52 | 9.63 |
Accrued Expenses | - | 35.65 | 43.17 | 53.73 | 37.83 |
Short-Term Debt | - | 25.78 | 32.81 | - | - |
Current Portion of Long-Term Debt | - | 18.19 | 20.68 | 3.29 | - |
Current Portion of Leases | - | 3.94 | 4.9 | 33.47 | 22.59 |
Current Unearned Revenue | - | 38.66 | 17.61 | 32.11 | 31.56 |
Other Current Liabilities | - | 6.53 | 20.08 | 13.26 | 11.62 |
Total Current Liabilities | - | 156.6 | 167.04 | 158.38 | 113.23 |
Long-Term Debt | - | 150.37 | 157.75 | 21.25 | - |
Long-Term Leases | - | 0.26 | 3.75 | 40.41 | 48.17 |
Long-Term Unearned Revenue | - | 7.21 | 4.31 | 11.8 | 20.7 |
Long-Term Deferred Tax Liabilities | - | 57.89 | 42.25 | 52.37 | 22.56 |
Other Long-Term Liabilities | - | 39.24 | 6.85 | 5.18 | 6.82 |
Total Liabilities | - | 411.58 | 381.95 | 289.39 | 211.48 |
Common Stock | - | 449.39 | 449.39 | 419.85 | 419.85 |
Additional Paid-In Capital | - | 1,045 | 1,031 | 668.47 | 670.68 |
Retained Earnings | - | -551.92 | -467.22 | -310.83 | -192.12 |
Comprehensive Income & Other | - | 325.47 | 224.81 | 266.2 | 108.54 |
Total Common Equity | 1,249 | 1,268 | 1,238 | 1,044 | 1,007 |
Minority Interest | - | 12.29 | - | 73.88 | 60.62 |
Shareholders' Equity | 1,292 | 1,280 | 1,238 | 1,118 | 1,068 |
Total Liabilities & Equity | - | 1,692 | 1,619 | 1,407 | 1,279 |
Total Debt | 211.66 | 198.54 | 219.89 | 98.42 | 70.76 |
Net Cash (Debt) | 136.11 | 61.65 | 141.01 | 153.17 | 336.98 |
Net Cash Growth | 120.77% | -56.28% | -7.94% | -54.55% | -53.24% |
Net Cash Per Share | 0.30 | 0.14 | 0.32 | 0.36 | 0.80 |
Filing Date Shares Outstanding | 426.76 | 449.39 | 449.39 | 419.85 | 419.85 |
Total Common Shares Outstanding | 455.99 | 449.39 | 449.39 | 419.85 | 419.85 |
Working Capital | - | 281.37 | 321.76 | 215.03 | 394.19 |
Book Value Per Share | 2.74 | 2.82 | 2.75 | 2.49 | 2.40 |
Tangible Book Value | 1,204 | 1,252 | 1,227 | 1,037 | 999.34 |
Tangible Book Value Per Share | 2.64 | 2.78 | 2.73 | 2.47 | 2.38 |
Buildings | - | 364.64 | 360.55 | 132.86 | - |
Machinery | - | 118.95 | 110.43 | 108.47 | 63.3 |
Construction In Progress | - | - | 10.13 | - | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.